@FierceMedDev: St. Jude's recalled Riata leads get slapped again. News | Follow @FierceMedDev
@MarkHFierce: BG Medicine has pulled a 510(k) filing for a cardiac disease test. Shockingly, investors weren't happy. Story | Follow @MarkHFierce
@DamianFierce: Despite losing $7M on three recalls, CareFusion posted an income boost for fiscal Q4. News | Follow @DamianFierce
> Guided Therapeutics says it has hashed out a plan with FDA officials to move forward with a PMA submission for its scanner device designed to screen for cervical diseases that lead to cancer. Progress on the noninvasive device comes after regulators issued a "not-approvable" letter on Jan. 20, 2012. Release
> Accelent, a manufacturing outsourcer for cardiology, endoscopy and orthopedic medical device companies, generated $130.2 million in net sales during its 2012 second quarter and lost $5.6 million. Release
> Actuated Medical gained FDA clearance for a portion of its TubeClear system, which is used to unclog feeding and decompression tubes. Story
> GeNO gained FDA clearance to market its new inhaled nitric oxide delivery system for ventilator use. Release
> Accelr8, a diagnostics/medical instrument company, is bringing in Steve Reichling as its new chief financial officer. He is a veteran executive who previously worked at Roche Tissue Diagnostics and Ventana Medical Systems, among other places. Release
> A Covidien executive sounds off on "the continuum of care," via MedCity News. Video
Biotech News
@FierceBiotech: Nanomaterial propels animals' heart attack-damaged hearts to repair themselves. Article | Follow @FierceBiotech
@JohnCFierce: Sen. Gillibrand wants to create a $200M marketing fund for biotechs. From petri dish to marketplace? Report | Follow @JohnCFierce
@RyanMFierce: Orbimed has backed Intercept Pharma in a $30M C round with lead drug for primary biliary cirrhosis. Release | Follow @RyanMFierce
> Forest makes nice with shareholders ahead of Icahn showdown. Article
> Intercept Pharma snags $30M round amid PhIII for liver-disease drug. News
> Industry Voices: Designing Probiotics - You Get What You Select For. Column
> FDA OKs Talon's drug for rare leukemia. More
Pharma News
@FiercePharma: Special reports this week: Top 11 Fastest-Growing Generics Companies | Top 10 Drug Advertising Spends -- Q1 2012. | Follow @FiercePharma
> New statins study sorts out diabetes risks. More
> Roche blockbuster Avastin does well as brain tumor therapy. Story
> Forest board yields in investor lawsuits. Article
> Generic cream price spikes have experts scratching their heads. Report